Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
AssigneeUniversitat Autonoma De Barcelona
InventorsVerónica Jiménez Cenzano, Fátima Bosch Tubert
Life of this patent
Estimating the term…
Abstract
The present invention relates to adeno-associated viral vector useful for transducing adipose tissue. The invention also relates to polynucleotides, plasmids, vectors and methods for the production of such adeno-associated viral vector. The invention also relates to gene therapy methods useful for the treatment of a disease that requires the regulation of the expression levels of a gene.
Claims20
A method for treating and/or preventing a disease which requires or may benefit from the expression of a polynucleotide of interest in the adipose tissue, the method comprising administering an adeno-associated viral vector (AAV) selected from the group consisting of AAV6, AAV7, AAV8 and AAV9 comprising a recombinant viral genome wherein said recombinant viral genome comprises adeno-associated virus Inverted Terminal Repeats (ITRs) and an expression cassette, said expression cassette comprising an adipose tissue-specific transcriptional regulatory region operatively linked to a polynucleotide of interest.
A method for treating and/or preventing a disease which requires or may benefit from the expression of a polynucleotide of interest in the adipose tissue, the method comprising administering an adeno-associated viral vector (AAV) selected from the group consisting of AAV6, AAV7, AAV8 and AAV9 comprising a recombinant viral genome wherein said recombinant viral genome comprises adeno-associated virus inverted Terminal Repeats (ITRs) and an expression cassette, said expression cassette comprising a transcriptional regulatory region operatively linked to a polynucleotide of interest, wherein said transcriptional regulatory region comprises a constitutive promoter and wherein said AAV further comprises at least one miRNA target sequence.
Dependencies are inferred from the claim text.